Critical Considerations on the Clinical Translation of Upconversion Nanoparticles (UCNPs): Recommendations from the European Upconversion Network (COST Action CM1403).

Oliveira H, Bednarkiewicz A, Falk A, Fröhlich E, Lisjak D, Prina-Mello A, Resch S, Schimpel C, Vrček IV, Wysokińska E, Gorris HH

Open source

DOI
10.1002/adhm.201801233
Published
2019 Jan
Container
Advanced healthcare materials
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/adhm.201801233,
  title = {Critical Considerations on the Clinical Translation of Upconversion Nanoparticles (UCNPs): Recommendations from the European Upconversion Network (COST Action CM1403).},
  author = {Oliveira H and Bednarkiewicz A and Falk A and Fröhlich E and Lisjak D and Prina-Mello A and Resch S and Schimpel C and Vrček IV and Wysokińska E and Gorris HH},
  year = {2019},
  journal = {Advanced healthcare materials},
  doi = {10.1002/adhm.201801233},
  url = {https://doi.org/10.1002/adhm.201801233}
}

RIS

TY  - JOUR
TI  - Critical Considerations on the Clinical Translation of Upconversion Nanoparticles (UCNPs): Recommendations from the European Upconversion Network (COST Action CM1403).
AU  - Oliveira H
AU  - Bednarkiewicz A
AU  - Falk A
AU  - Fröhlich E
AU  - Lisjak D
AU  - Prina-Mello A
AU  - Resch S
AU  - Schimpel C
AU  - Vrček IV
AU  - Wysokińska E
AU  - Gorris HH
PY  - 2019
JO  - Advanced healthcare materials
DO  - 10.1002/adhm.201801233
UR  - https://doi.org/10.1002/adhm.201801233
ER  - 

APA

H, O., A, B., A, F., E, F., D, L., A, P., S, R., C, S., IV, V., E, W., & HH, G. (2019). Critical Considerations on the Clinical Translation of Upconversion Nanoparticles (UCNPs): Recommendations from the European Upconversion Network (COST Action CM1403).. Advanced healthcare materials. https://doi.org/10.1002/adhm.201801233

Source records